FDA Drug Application (203865) for NORGESTIMATE AND ETHINYL ESTRADIOL by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number203865
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG;0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNORGESTIMATE AND ETHINYL ESTRADIOL
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by AMNEAL PHARMS